Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05227053 · ClinicalTrials.gov registry record
STOP AF First Post-Approval Study
A clinical trial of Paroxysmal Atrial Fibrillation, sponsored by Medtronic Cardiac Ablation Solutions.
- Recruiting
- Registry status
- 200
- Enrollment target
- 13
- Study locations
NCT05227053: Recruiting study of Paroxysmal Atrial Fibrillation, sponsored by Medtronic Cardiac Ablation Solutions.
NCT05227053 is a study of Paroxysmal Atrial Fibrillation that is actively recruiting participants, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 200 participants, below the 851-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (76% lower). The trial reports 13 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05227053, a study of Paroxysmal Atrial Fibrillation, is actively recruiting participants, sponsored by Medtronic Cardiac Ablation Solutions.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 13
- Study locations
Study Summary
The STOP AF First PAS is a prospective, global, multi-center, observational trial.
Primary Outcome
Estimate the 36-month freedom from Atrial Fibrillation (AF) /atrial flutter (AFL) /Atrial Tachycardia (AT) recurrence using the Arctic Front™ cardiac cryoablation catheter System.
Conditions Studied
Interventions
- DEVICE Arctic Front™ Cardiac Cryoablation Catheter
Study Locations (13)
Florida
- BayCare Medical Group Cardiology - Clearwater
- Heart Rhythm Solutions - Davie
Tennessee
- Stern Cardiovascular Foundation - Germantown
- University of Tennessee Methodist Physicians - Memphis
Alaska
- Alaska Heart Institute - Anchorage
Connecticut
- Cardiology Associates of Fairfield County - Stamford
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Iowa
- Iowa Heart - West Des Moines
Louisiana
- Our Lady of the Lake - Baton Rouge
Massachusetts
- Southcoast Health System - North Dartmouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2028-04 |
What NCT05227053 shows while recruiting
NCT05227053 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 851-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Arctic Front™ Cardiac Cryoablation Catheter is the first listed.
NCT05227053 lists 13 locations in 11 states (Florida, Tennessee, Alaska).
Frequently Asked Questions
What is clinical trial NCT05227053 about?
NCT05227053 is a clinical study titled "STOP AF First Post-Approval Study". The STOP AF First PAS is a prospective, global, multi-center, observational trial.
What is the current status of trial NCT05227053?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2022-04-28. Estimated completion is 2028-04.
What conditions does trial NCT05227053 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation.
What interventions are being tested in trial NCT05227053?
The interventions under investigation include: Arctic Front™ Cardiac Cryoablation Catheter (DEVICE).
Who is sponsoring clinical trial NCT05227053?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05227053 being conducted?
This trial has 13 study locations across Alaska, Connecticut, District of Columbia, Florida, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05227053's enrollment target sits among peer trials
200 14th of 24 higher than 10 of 24 other Paroxysmal Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Paroxysmal Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
RECRUITING
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RECRUITING
-
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
RECRUITING
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
-
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI